Patents
Patents for C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
11/2007
11/27/2007US7300928 Benzimidazolidinone derivatives as muscarinic agents
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/22/2007US20070270457 Quinolinone-carboxamide compounds as 5-HT, receptor agonists
11/22/2007US20070270456 M3 Muscarinic Acetylcholine Receptor Antagonists
11/20/2007US7297693 furan-, pyrrole- or thiophenecarboxamides ring-substituted with a hydroxyimino-fused ring and a nitrogen heteroarene; e.g., 5-[5-(1-Morpholin-4-yl-methanoyl)-2-pyridin-4-yl-furan-3-yl]-indan-1-one oxime;treating neurotraumatic diseases, cancer, neurodegeneration, pain, migraine and cardiac hypertrophy
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070265241 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/14/2007EP1853599A1 Novel polymorph of mutilin
11/14/2007EP1853597A1 Benzoxazole carboxamides for treating cinv and ibs-d
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007CN100348598C Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
11/13/2007US7294636 Chemical compounds
11/13/2007CA2425557C Anticholinergic agents that can be used as medicaments and method for the production thereof
11/08/2007US20070259863 Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives
11/07/2007CN100347170C Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
11/06/2007US7291737 Cocaine receptor binding ligands
11/06/2007US7291631 aminoalkylpyridines, e.g., N-(1H-benzimidazol-2-ylmethyl)-N-(3-methylpyridin-2-ylmethyl)-butane-1,4-diamine; treating HIV infection and inflammatory conditions such as rheumatoid arthritis; elevating progenitor and stem cell counts, as well as white blood cell counts
11/06/2007US7291611 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain
11/06/2007US7291609 Specific glucocorticosteroid compound having anti-inflammatory activity
11/01/2007WO2007103187A3 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
11/01/2007WO2007079239A3 Bicyclic nitrogen compounds as modulators of ghrelin receptor and uses thereof
11/01/2007WO2007075858A3 Novel forms of tiotropium bromide and processes for preparation thereof
11/01/2007WO2004062610A3 4',4''-SUBSTITUTED 3α-(DIPHENYLMETHOXY)TROPANE ANALOGS FOR TREATMENT OF MENTAL DISORDERS
10/2007
10/31/2007EP1848716A1 Crystalline form of an indazole-carboxamide compound
10/31/2007EP1848428A2 Thiazole amides, imidazole amides and related analogues
10/30/2007US7288536 For therapy of skin diseases such as eczema, psoriasis, allergic dermatitis neurodermatitis, pruritis and hypersensitivity reactions; inflammatory conditions of the nose, throat or lungs such as asthma (including allergen-induced asthmatic reactions), rhinitis (including hayfever), nasal polyps
10/25/2007WO2002057262A3 Bicyclic amines as insecticides
10/18/2007WO2007116313A2 Pyrrolidine derivatives as modulators of chemokine ccr5 receptors
10/18/2007US20070244150 Muscarinic Acetylcholine Receptor Antagonists
10/18/2007US20070244149 Tropane analogs and methods for inhibition of monoamine transport
10/18/2007CA2647448A1 Pyrrolidine derivatives as modulators of chemokine ccr5 receptors
10/17/2007EP1390699B1 Metering method for particulate material
10/17/2007CN101056876A Process for preparing substituted 8-azabicyclo[3.2.1] octan-3-ols
10/16/2007US7282509 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
10/11/2007US20070238752 Muscarinic Acetylcholine Receptor Antagonists
10/11/2007US20070238751 Muscarinic Acetylcholine Receptor Antagonists
10/04/2007WO2007111323A1 Ureide derivative and use thereof for medical purposes
10/04/2007US20070232666 Novel Chromen-2-One Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
10/04/2007US20070232646 Tropane prodrugs with central nervous system activity
10/04/2007US20070232641 exo-3-(3,4-Dichloro-phenoxy)-9-methyl-9-aza-bicyclo[3.3.1]nonane; central nervous system disorders
10/04/2007CA2647603A1 Ureide derivative and use thereof for medical purposes
10/03/2007EP1838705A2 3,8-substituted 8-aza-bicyclo [3.2.1] octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/03/2007CN101048393A Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
10/02/2007US7276521 Muscarinic acetylcholine receptor antagonists
10/02/2007US7276520 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
09/2007
09/27/2007WO2007081890A3 Production of dolasetron
09/27/2007WO2006076317A9 Aminophenyl derivatives as selective androgen receptor modulators
09/26/2007EP1836202A2 Aminophenyl derivatives as selective androgen receptor modulators
09/26/2007EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
09/26/2007CN101044140A Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
09/25/2007US7273857 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes
09/25/2007CA2305468C 8-azabicyclo [3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors
09/20/2007WO2007104652A2 Non-peptidic renin inhibitors nitroderivatives
09/20/2007WO2007081889A9 Production of dolasetron
09/20/2007US20070219197 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives
09/20/2007CA2646235A1 Non-peptidic renin inhibitors nitroderivatives
09/19/2007EP1833826A2 Tricyclic delta-opioid modulators
09/19/2007EP1833825A1 Tricyclic delta-opioid modulators
09/19/2007CN101039941A Aminopiperidine derivatives, preparation thereof and therapeutic use thereof
09/19/2007CN101039940A Tricyclic delta-opioid modulators
09/18/2007US7271176 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation
09/13/2007CA2646409A1 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
09/12/2007EP1831211A1 Indazole-carboxamide compounds
09/12/2007EP1831210A1 8-aza-bicyclo[3.2.1]octane derivatives with an activity on chemokine ccr5 receptors
09/12/2007EP1737840B1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
09/11/2007US7268232 Androgen receptor modulators and method of treating disease using the same
09/11/2007US7268150 2-cyano-4-fluoropyrrolidine derivative or its salt
09/07/2007WO2007100851A1 Therapeutic compounds
09/07/2007WO2007062058A3 Carbamate compounds as 5-ht4 receptor agonists
09/07/2007CA2644068A1 Therapeutic compounds
09/06/2007US20070208060 Compounds for treating inflammatory diseases
09/06/2007US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
09/06/2007US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them
09/05/2007EP1828176A1 Tetrahydroquinoline analogues as muscarinic agonists
09/04/2007USRE39820 Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
09/04/2007US7265133 Biphenylylaminocarbonyl-amino- or -oxypiperidine derivatives, e.g., biphenyl-2-ylcarbamic acid 1-[2-({4-[(4-hydroxybenzylamino)methyl]benzoyl}methylamino)ethyl]piperidin-4-yl ester; treating bronchodilation and COPD
08/2007
08/30/2007WO2007097976A1 Process for preparing intermediates to 5-ht4 receptor agonist compounds
08/30/2007CA2637214A1 Process for preparing 8-azabicylo[3.2.1]octan-3-one intermediates to 5-ht4 receptor agonist compounds
08/29/2007EP1824805A1 Method for preparation of organofluoro compounds in alcohol solvents
08/29/2007EP1643998B1 Dual nk1/nk3 antagonists for treating schizophrenia
08/28/2007US7262206 Having inhibiting effect on protein kinases, particularly an inhibiting effect on the activity of glycogen synthase kinase (GSK), for therapy of type II diabetes mellitus, diabetes associated disorders such as diabetic neuropathy, degenerative neurological diseases such as Alz-heimer's disease, stroke
08/23/2007WO2007093604A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/23/2007WO2007093366A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/23/2007WO2007081889A3 Production of dolasetron
08/23/2007US20070197580 To treat irritable bowel syndrome; side effect reduction, improved pharmacodynamics and safety, more potent and selective; 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group
08/23/2007US20070196270 Compounds As Ccri Antagonists
08/23/2007CA2641916A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/23/2007CA2636617A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/22/2007EP1819705A1 Method for preparing hexahydro-8-hydroxy-2,6-methano-2h-chinolizin-3(4h)-one esters
08/22/2007EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
08/22/2007CN101023081A Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/16/2007WO2007092400A1 Aminophenyl derivatives as selective androgen receptor modulators
08/16/2007WO2007075838A3 Pure and stable tiotropium bromide
08/16/2007US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning
08/16/2007US20070191391 Urotensin II receptor antagonists
08/16/2007US20070191364 Aminopiperidine derivatives, preparation thereof and therapeutic use thereof
08/16/2007US20070191361 Aminotropane derivatives, preparation thereof and therapeutic use thereof
08/15/2007EP1817834A1 Method and installation means for installing an electrical machine
08/09/2007WO2007089683A1 Amido compounds and their use as pharmaceuticals
08/09/2007WO2007088557A1 Process for highly pure crystalline granisetron base
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 53